TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3627711

Group type: EXPERIMENTAL
Intervention: Constantly monitored (CM) group with continuous transcutaneous oxygen monitoring (tcPO2)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Standard care (SC) group with intermittent monitoring of tcPO2
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: CM group
Number of subjects: 296

Group type: COMPARATOR
Intervention: SC group
Number of subjects: 296

Group type: COMPARATOR
Intervention: Infants over 1000 g birthweight in SC group
Number of subjects: 296
Study: 30746055

Group type: EXPERIMENTAL
Intervention: Sets of domain-specific exercises (SRT+CRT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sets of nondomain-specific exercises (SRT+PBO)
Number of subjects: 110
Study: 27718284

Group type: EXPERIMENTAL
Intervention: C-NDL procedure
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: endopelvic free anchorage procedure
Number of subjects: 209

Group type: COMPARATOR
Intervention: TVT-O procedure
Number of subjects: 209
Study: 25406953

Group type: EXPERIMENTAL
Intervention: Topical insulin-like growth factor-1 (IGF-1) therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intratympanic corticosteroid therapy (Dexamethasone)
Number of subjects: 120
Study: 23962957

Group type: EXPERIMENTAL
Intervention: Form-only condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Picture-associated condition
Number of subjects: 0
Study: 22716204

Group type: EXPERIMENTAL
Intervention: metformin (3 g daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 41
Study: 20116969

Group type: EXPERIMENTAL
Intervention: AI-4/PEP-4
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AI-6/PEP-4
Number of subjects: 20

Group type: COMPARATOR
Intervention: VS
Number of subjects: 20
Study: 18050189

Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 44

Group type: COMPARATOR
Intervention: Methotrexate (MTX) plus intravenous methylprednisolone (IV MP)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Methotrexate (MTX) plus infliximab
Number of subjects: 44
Study: 16085528

Group type: EXPERIMENTAL
Intervention: Contingency management (CM; payment for chewing at least 12 pieces/day on 10 of 15 intervention days, n = 34) plus standard treatment (ST) and brief feedback (BF)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Brief feedback (BF; n = 32) plus standard treatment (ST)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard treatment (ST; n = 31)
Number of subjects: 97
Study: 12173710

Group type: EXPERIMENTAL
Intervention: Intravenous glutathione twice a day for 5 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline solution twice a day for 5 days
Number of subjects: 40
Study: 10226978

Group type: EXPERIMENTAL
Intervention: Theophylline (300-500 mg orally at night for 4-22 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (nCPAP therapy)
Number of subjects: 50
Study: 8767921

Group type: EXPERIMENTAL
Intervention: IS-5-MN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: s.r. ISDN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: nitroglycerine-patches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous application of organic nitrates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrate-free interval of 12 to 18 hours
Number of subjects: 0
Study: 1457233

Group type: EXPERIMENTAL
Intervention: Acupressure wrist band
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo wrist band
Number of subjects: 6

Group type: COMPARATOR
Intervention: No wrist band condition
Number of subjects: 6
Study: 6148877

Group type: EXPERIMENTAL
Intervention: 40 mg nadolol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 2 mg diazepam
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 31349876

Group type: EXPERIMENTAL
Intervention: Secukinumab (anti-IL-17A antibody) administered over 24 weeks
Number of subjects: 20
Study: 29687524

Group type: EXPERIMENTAL
Intervention: Trauma Affect Regulation: Guide for Education and Therapy (TARGET)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Prolonged Exposure (PE)
Number of subjects: 31
Study: 26211482

Group type: EXPERIMENTAL
Intervention: Subconjunctival glucose (50%)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Iso‐osmotic (8%) saline
Number of subjects: 5
Study: 25231697

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) therapy for 6 months
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Functional endoscopy
Number of subjects: 71
Study: 22617574

Group type: EXPERIMENTAL
Intervention: Irrigation
Number of subjects: 236

Group type: COMPARATOR
Intervention: No irrigation
Number of subjects: 236
Study: 20076851

Group type: EXPERIMENTAL
Intervention: Intramyocardial delivery of autologous bone marrow mononuclear cells (BM-MNC)
Number of subjects: 100
Study: 18095198

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.7 microg/kg loading, 10 microg bolus dose with 5 minutes lockout time)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.3 microg/kg loading, 20 microg bolus dose with 3 minutes lockout time)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (saline solution without analgesic)
Number of subjects: 120
Study: 16001776

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, and beta‐adrenergic blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic implantable cardioverter defibrillator (ICD) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine prophylactic use of ICDs
Number of subjects: 0
Study: 12010228

Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 9925529

Group type: EXPERIMENTAL
Intervention: Single dose of mefloquine (25 mg/kg) on day 2 with food
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Split dose of mefloquine (15 mg/kg on day 2 and 10 mg/kg on day 3) with food
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Single dose of mefloquine (25 mg/kg) on day 0 without food
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Single dose of mefloquine (25 mg/kg) on day 2 without food
Number of subjects: 120
Study: 7789044

Group type: EXPERIMENTAL
Intervention: Intraperitoneal insulin delivery
Number of subjects: 6

Group type: COMPARATOR
Intervention: Subcutaneous insulin administration
Number of subjects: 6
Study: 1419641

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study: 6236952

Group type: EXPERIMENTAL
Intervention: Desogestrel 0.125 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Desogestrel 0.250 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Desogestrel 0.500 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lynestrenol 5 mg
Number of subjects: 8
Study: 31352573

Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 30232658

Group type: EXPERIMENTAL
Intervention: Vasopressin–Steroids–Epinephrine combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Epinephrine alone
Number of subjects: 0
Study: 27903561

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) programme
Number of subjects: 80

Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 80
Study: 23836299

Group type: EXPERIMENTAL
Intervention: Rehabilitation programme including exercises and cognitive-behavioural therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Exercises alone (control group)
Number of subjects: 130
Study: 22532074

Group type: EXPERIMENTAL
Intervention: Tunneled version of the website with less user control
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: High user control version of the website (freedom of choice to skip pages)
Number of subjects: 668

Group type: COMPARATOR
Intervention: Control group (not exposed to the website)
Number of subjects: 668
Study: 20306079

Group type: EXPERIMENTAL
Intervention: Moderate concentration contrast medium
Number of subjects: 159

Group type: COMPARATOR
Intervention: High concentration contrast medium
Number of subjects: 159
Study: 17889126

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 1558

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 1558
Study: 16251074

Group type: EXPERIMENTAL
Intervention: Computer Aided Detection (CAD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No CAD (before CAD)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CAD
Number of subjects: 120
Study: 12153599

Group type: EXPERIMENTAL
Intervention: Oestrogen plus methyltestosterone (1.25 mg esterified oestrogen and 2.5 mg methyltestosterone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oestrogen only (1.25 mg esterified oestrogen)
Number of subjects: 0
Study: 10199530

Group type: EXPERIMENTAL
Intervention: Silver-coated catheters
Number of subjects: 67

Group type: COMPARATOR
Intervention: Uncoated control catheters
Number of subjects: 67
Study: 7587977

Group type: EXPERIMENTAL
Intervention: Cocaine dependence with alcohol abuse (COC-ETOH group)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Cocaine dependence only (COC-only group)
Number of subjects: 73
Study: 2145499

Group type: EXPERIMENTAL
Intervention: 5% tea-tree oil gel
Number of subjects: 124

Group type: COMPARATOR
Intervention: 5% benzoyl peroxide lotion
Number of subjects: 124
Study: 154748

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 microgram and salbutamol 200 microgram
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 microgram
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 microgram
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 microgram and salbutamol 200 microgram together
Number of subjects: 24
Study: 31999862

Group type: EXPERIMENTAL
Intervention: Algorithm for diagnosing IgE-mediated food allergy
Number of subjects: 69
Study: 31033434

Group type: EXPERIMENTAL
Intervention: Adalimumab plus methotrexate (MTX)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo plus methotrexate (MTX)
Number of subjects: 90
Study: 28431003

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: High-dose BMCs (hiBMCs)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Low-dose BMCs (loBMCs)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Irradiated high-dose BMCs (irradiated hiBMCs)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Irradiated low-dose BMCs (irradiated loBMCs)
Number of subjects: 153
Study: 25849685

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 0
Study: 23811060

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone (BUP)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Buprenorphine-naloxone (DETOX)
Number of subjects: 152
Study: 21889074

Group type: EXPERIMENTAL
Intervention: Treated subjects with fixed orthodontic appliances
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 19153741

Group type: EXPERIMENTAL
Intervention: Virtual otoscopy and 3D ossicular reconstruction
Number of subjects: 33

Group type: COMPARATOR
Intervention: 2D images (HRCT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: HRCT and 2D reformatted images
Number of subjects: 33
Study: 17120974

Group type: EXPERIMENTAL
Intervention: Cha-em Thai mouthwash
Number of subjects: 67
Study: 15047458

Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin (epoietin alpha and beta, darbepoietin-alpha, EPO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No anti-anaemic treatment
Number of subjects: 30
Study: 11380284

Group type: EXPERIMENTAL
Intervention: Proliferative phase
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: GnRHa treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Proliferative phase myometrium
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: GnRHa treated patients
Number of subjects: 27

Group type: COMPARATOR
Intervention: Secretory phase
Number of subjects: 27
Study: 8993821

Group type: EXPERIMENTAL
Intervention: Anesthesia infusion sleeve (AIS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard sheath for vascular access
Number of subjects: 80
Study: 8496514

Group type: EXPERIMENTAL
Intervention: Peer teaching
Number of subjects: 50

Group type: COMPARATOR
Intervention: Instructor teaching
Number of subjects: 50
Study: 2894215

Group type: EXPERIMENTAL
Intervention: Ketanserin (mean daily dose 71 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ketanserin + Bendrofluazide
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ketanserin + Atenolol
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 56
Study: 29966855

Group type: EXPERIMENTAL
Intervention: Detached mindfulness intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-active control
Number of subjects: 52
Study: 27075480

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise protocol for the foot-ankle for 8 weeks, with 1 directly supervised session and 3 remotely supervised sessions per week, followed by 10 months of web-enabled software supervision three times a week
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise protocol for the foot-ankle
Number of subjects: 111
Study: 26580879

Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (9 units)
Number of subjects: 20

Group type: COMPARATOR
Intervention: AbobotulinumtoxinA (27 units)
Number of subjects: 20
Study: 23776081

Group type: EXPERIMENTAL
Intervention: Medela Symphony (pump S)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Philips AVENT Twin electronic pump (pump A)
Number of subjects: 71
Study: 20230606

Group type: EXPERIMENTAL
Intervention: SHARP-at work intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study: 18677023

Group type: EXPERIMENTAL
Intervention: Subcutaneous growth hormone (GH) starting dose 2 microg/kg/d, increased to maximum dose of 6 microg/kg/d for 18 months.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Matching placebo for 18 months.
Number of subjects: 56
Study: 15933559

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) 50 mg/m for infants >28 days of age
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) 25 mg/m for infants < or =28 days of age, escalated to 50 mg/m
Number of subjects: 44

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) treatment
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) treatment
Number of subjects: 44
Study: 12868552

Group type: EXPERIMENTAL
Intervention: Ticarcillin‐clavulanic acid plus amikacin (TCA)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin (CFA)
Number of subjects: 127
Study: 10392222

Group type: EXPERIMENTAL
Intervention: Instillation of 5 mL of normal saline before endotracheal suctioning
Number of subjects: 35

Group type: COMPARATOR
Intervention: Endotracheal suctioning without saline
Number of subjects: 35
Study: 8546551

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole-trimethoprim (double-strength tablet three times a week)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dapsone (100 mg daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine (dose not specified)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral regimens (compared to aerosolized pentamidine)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Different regimens (general comparison)
Number of subjects: 100
Study: 2071316

Group type: EXPERIMENTAL
Intervention: Gastric balloon only
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Gastric balloon and prescribed 1000 kcal/day diet
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 1000 kcal/day diet only
Number of subjects: 86

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 86
Study: 6665832

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation for 69 days
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation for 47 days
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo for 69 days
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo for 47 days
Number of subjects: 204
Study: 30993591

Group type: EXPERIMENTAL
Intervention: Bully-victim category
Number of subjects: 471

Group type: COMPARATOR
Intervention: Neutrals
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Bully-victims
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Assessment of bullying problems
Number of subjects: 471
Study: 28600725

Group type: EXPERIMENTAL
Intervention: Oxycodone DETERx
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 26923083

Group type: EXPERIMENTAL
Intervention: Quinvaxem in cPAD injection system
Number of subjects: 400

Group type: COMPARATOR
Intervention: Quinvaxem in single-dose vial
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Both groups (cPAD and single-dose vial)
Number of subjects: 400
Study: 25066559

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 4372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4372
Study: 21960048

Group type: EXPERIMENTAL
Intervention: Balneotherapy plus exercise for ten sessions
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physical modalities plus exercise
Number of subjects: 60
Study: 19093148

Group type: EXPERIMENTAL
Intervention: Absorbable metal stents (AMSs)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 117

Group type: COMPARATOR
Intervention: PTA alone
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: PTA followed by AMS implantation
Number of subjects: 117
Study: 19080533

Group type: EXPERIMENTAL
Intervention: Combination therapy with salmeterol/fluticasone (50/250 microg) twice daily and tiotropium 18 microg once daily (n = 33, M/F: 23/10)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Combination therapy with salmeterol/fluticasone and tiotropium
Number of subjects: 126

Group type: COMPARATOR
Intervention: Salmeterol/fluticasone (50/250 microg) twice daily (n = 32, M/F: 24/8)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Tiotropium 18 microg once daily (n = 32, M/F: 23/9)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Blank control group (n = 29, M/F: 22/7)
Number of subjects: 126
Study: 15680826

Group type: EXPERIMENTAL
Intervention: CABG + ventral cardiac denervation (group B)
Number of subjects: 70

Group type: COMPARATOR
Intervention: CABG (group A)
Number of subjects: 70
Study: 12118027

Group type: COMPARATOR
Intervention: PVI 5-FU (300 mg/m²/d for a maximum of 24 weeks)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: PVI 5-FU plus MMC (7 mg/m² every 6 weeks for four courses)
Number of subjects: 208

Group type: COMPARATOR
Intervention: PVI 5-FU
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: PVI 5-FU plus MMC
Number of subjects: 208
Study: 10096482

Group type: EXPERIMENTAL
Intervention: Percutaneous mitral balloon valvuloplasty (PMV)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (normal coronary arteries and LV function)
Number of subjects: 19
Study: 7586111

Group type: EXPERIMENTAL
Intervention: TOF monitoring (Group A; n = 20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No TOF monitoring (Group B; n = 19)
Number of subjects: 39
Study: 2303688

Group type: EXPERIMENTAL
Intervention: Emergency sclerotherapy (1‐6 h after presentation)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Delayed sclerotherapy (more than 24 h from presentation)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Emergency sclerotherapy with larger volumes of sclerosant (mean of 26 ml)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Emergency sclerotherapy
Number of subjects: 84
Study: 7374618

Group type: EXPERIMENTAL
Intervention: oxygen-multistep-therapy
Number of subjects: 14
Study: 30882562

Group type: EXPERIMENTAL
Intervention: Intervention group (Girls on the Move)
Number of subjects: 1519

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1519
Study: 27919633

Group type: EXPERIMENTAL
Intervention: High dose inactivated influenza vaccine (HD IIV)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard dose inactivated influenza vaccine (SD IIV)
Number of subjects: 50
Study: 26391700

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate/ethinyloestradiol with metformin
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate/ethinyloestradiol without metformin
Number of subjects: 445

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: PCOS without insulin resistance (IR)
Number of subjects: 445
Study: 24459172

Group type: EXPERIMENTAL
Intervention: Task-oriented exercises with early full weight-bearing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open chain kinetic exercises with partial weight-bearing and walking aids
Number of subjects: 100
Study: 21780053

Group type: EXPERIMENTAL
Intervention: Sharp dissection with knife or scissors and excision and ligation of scar tissue using absorbable suture material
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dissection with electrocoagulation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dissection with ultrasound (Ultracision Harmonic Scalpel)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 18719045

Group type: EXPERIMENTAL
Intervention: 500 microg/kg THC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 17499398

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (0.3g/kg/day)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (isonitrogenous placebo supplementation)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both groups (glutamine and control)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 102
Study: 15552361

Group type: EXPERIMENTAL
Intervention: Familiarization with a diamond appearing in distinct locations to the left or right of a vertical bar
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Familiarization with a diamond appearing in distinct locations with a bar oriented at 45 degrees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiment 4 (not detailed in the abstract)
Number of subjects: 0